BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Tat-CIAPIN1 protein prevents against cytokine-induced cytotoxicity in pancreatic RINm5F β-cells

  • Yeo, Hyeon Ji (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) ;
  • Shin, Min Jea (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) ;
  • Kim, Dae Won (Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University) ;
  • Kwon, Hyeok Yil (Department of Physiology, College of Medicine, Hallym University) ;
  • Eum, Won Sik (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University) ;
  • Choi, Soo Young (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
  • Received : 2021.03.23
  • Accepted : 2021.04.20
  • Published : 2021.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cytokines activate inflammatory signals and are major mediators in progressive β-cell damage, which leads to type 1 diabetes mellitus. We recently showed that the cell-permeable Tat-CIAPIN1 fusion protein inhibits neuronal cell death induced by oxidative stress. However, how the Tat-CIAPIN1 protein affects cytokine-induced β-cell damage has not been investigated yet. Thus, we assessed whether the Tat-CIAPIN1 protein can protect RINm5F β-cells against cytokine-induced cytotoxicity. In cytokine-exposed RINm5F β-cells, the transduced Tat-CIAPIN1 protein elevated cell survivals and reduced reactive oxygen species (ROS) and DNA fragmentation levels. The Tat-CIAPIN1 protein reduced mitogen-activated protein kinases (MAPKs) and NF-κB activation levels and elevated Bcl-2 protein, whereas Bax and cleaved Caspase-3 proteins were decreased by this fusion protein. Thus, the protection of RINm5F β-cells by the Tat-CIAPIN1 protein against cytokine-induced cytotoxicity can suggest that the Tat-CIAPIN1 protein might be used as a therapeutic inhibitor against RINm5F β-cell damage.

Keywords

Acknowledgement

This research was supported by Basic Science Research Program (2017R1D1A3B04032007 & 2019R1A6A1A11036849) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education.

References

  1. Welters A and Lammert E (2014) Diabetes Mellitus. In: Lammert E, Zeeb M (eds) Metabolism of human diseases: organ physiology and pathophysiology. Springer, Vienna, 163-173
  2. Katsarou A, Gudbjornsdottir S, Rawshani A et al (2017) Type 1 diabetes mellitus. Nat Rev Dis Primers 3, 17016. https://doi.org/10.1038/nrdp.2017.16
  3. Lukic ML, Pejnovic N and Lukic A (2014) New insight into early events in type 1 diabetes: role for islet stem cell exosomes. Diabetes 63, 835-837 https://doi.org/10.2337/db13-1786
  4. Patterson CC, Gyurus E, Rosenbauer J et al (2012) Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 55, 2142-2147 https://doi.org/10.1007/s00125-012-2571-8
  5. Patterson CC, Dahlquist GG, Gyurus E, Green A and Soltesz G (2009) EURODIAB Study Group: incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373, 2027-2033 https://doi.org/10.1016/S0140-6736(09)60568-7
  6. Imai Y, Dobrian AD, Weaver JR et al (2013) Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes Obes Metab 15, S117-S129
  7. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S and Eizirik DL (2005) Mechanisms of pancreatic beta cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54, S97-S107 https://doi.org/10.2337/diabetes.54.suppl_2.S97
  8. Corbett JA and McDaniel ML (1992) Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 41, 897-903
  9. Shibayama H, Takai E, Matsumura I et al (2004) Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J Exp Med 199, 581-592 https://doi.org/10.1084/jem.20031858
  10. Hao Z, Li X, Qiao T, du R, Zhang G and Fan D (2006) Subcellular localization of CIAPIN1. J Histochem Cytochem 54, 1437-1444 https://doi.org/10.1369/jhc.6A6960.2006
  11. Zhang Y, Fang J and Ma H (2018) Inhibition of miR-182-5p protects cardiomyocytes from hypoxia-induced apoptosis by targeting CIAPIN1. Biochem Cell Biol 96, 646-654 https://doi.org/10.1139/bcb-2017-0224
  12. Huang Z, Su GF, Hu WJ, Bi XX, Zhang L and Wan G (2017) The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms. Eur Rev Med Pharmacol Sci 21, 3054-3060
  13. Hao Z, Li X, Qiao T, Du R, Hong L and Fan D (2006) CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol Ther 5, 261-266 https://doi.org/10.4161/cbt.5.3.2381
  14. Li X, Wu K and Fan D (2010) CIAPIN1 as a therapeutic target in cancer. Expert Opin Ther Targets 14, 603-610 https://doi.org/10.1517/14728221003774127
  15. Li X, Fan R, Zou X et al (2008) Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA. Mol Biol 42, 102-109
  16. Wang X, Pan J and Li J (2015) Cytokine-induced apoptosis inhibitor 1 inhibits the growth and proliferation of multiple myeloma. Mol Med Res 12, 2056-2062 https://doi.org/10.3892/mmr.2015.3656
  17. Park KA, Yun N, Shin DI et al (2011) Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain. J Neural Transm 118, 433-444 https://doi.org/10.1007/s00702-010-0490-8
  18. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP and Tergaonkar V (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32, 1-15 https://doi.org/10.1042/BSR20100136
  19. Sethi G and Tergaonkar V (2009) Potential pharmacological control of the NF-kappaB pathway. Trends Pharmacol Sci 30, 313-321 https://doi.org/10.1016/j.tips.2009.03.004
  20. Lemmon MA and Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134 https://doi.org/10.1016/j.cell.2010.06.011
  21. Gump JM and Dowdy SF (2007) TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 13, 443-448 https://doi.org/10.1016/j.molmed.2007.08.002
  22. Moon JI, Han MJ, Yu SH et al (2019) Enhanced delivery of protein fused to cell penetrating peptides to mammalian cells. BMB Rep 52, 324-329 https://doi.org/10.5483/BMBRep.2019.52.5.195
  23. Frankel AD and Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193 https://doi.org/10.1016/0092-8674(88)90263-2
  24. Kardani K, Milani A, Shabani SH and Bolhassani A (2019) Cell penetrating peptides: the potent multi-cargo intracellular carriers. Expert Opin Drug Deliv 16, 1227-1258 https://doi.org/10.1080/17425247.2019.1676720
  25. Lindsay MA (2002) Peptide-mediated cell delivery: application in protein target validation. Curr Opin Pharmacol 2, 587-594 https://doi.org/10.1016/S1471-4892(02)00199-6
  26. Wadia JS and Dowdy SF (2003) Modulation of cellular function by TAT mediated transduction of full length proteins. Curr Protein Pept Sci 4, 97-104 https://doi.org/10.2174/1389203033487289
  27. Snyder EL and Dowdy SF (2004) Cell penetrating peptides in drug delivery. Pharm Res 21, 389-393 https://doi.org/10.1023/B:PHAM.0000019289.61978.f5
  28. Yeo HJ, Shin MJ, Yeo EJ et al (2019) Tat-CIAPIN1 inhibits hippocampal neuronal cell damage through the MAPK and apoptotic signaling pathways. Free Radic Biol Med 135, 68-78 https://doi.org/10.1016/j.freeradbiomed.2019.02.028
  29. Yeo HJ, Shin MJ, You JH et al (2019) Transduced Tat-CIAPIN1 reduces the inflammatory response on LPS- and TPA-induced damages. BMB Rep 52, 695-699 https://doi.org/10.5483/BMBRep.2019.52.12.245
  30. van den Berg A and Dowdy SF (2011) Protein transduction domain delivery of therapeutic macromolecules. Curr Opin Biotechnol 22, 888-893 https://doi.org/10.1016/j.copbio.2011.03.008
  31. Dietz GP (2010) Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr Pharm Biotechnol 11, 167-174 https://doi.org/10.2174/138920110790909731
  32. Kim DW, Shin MJ, Choi YJ et al (2018) Tat-ATOX1 inhibits inflammatory responses via regulation of MAPK and NF-κB pathways. BMB Rep 51, 654-659 https://doi.org/10.5483/BMBRep.2018.51.12.248
  33. Shin MJ, Kim DW, Lee YP et al (2013) Tat-glyoxalase protein inhibits against ischemic neuronal cell damage and ameliorates ischemic injury. Free Radic Biol Med 67, 195-210 https://doi.org/10.1016/j.freeradbiomed.2013.10.815
  34. Shin MJ, Kim DW, Jo HS et al (2016) Tat-PRAS40 prevent hippocampal HT-22 cell death and oxidative stress induced animal brain ischemic insults. Free Radic Biol Med 97, 250-262 https://doi.org/10.1016/j.freeradbiomed.2016.06.009
  35. Cho SB, Eum WS, Shin MJ et al (2019) Transduced Tat-aldose reductase protects hippocampal neuronal cells against oxidative stress-induced damage. Exp Neurobiol 28, 612-627 https://doi.org/10.5607/en.2019.28.5.612
  36. Herbig ME, Weller K, Krauss U, Beck-Sickinger AG, Merkle HP and Zerbe O (2005) Membrane surfaceassociated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. Biophys J 89, 4056-4066 https://doi.org/10.1529/biophysj.105.068692
  37. Wadia JS, Stan RV and Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10, 310-315 https://doi.org/10.1038/nm996
  38. El-Sayed A, Futaki S and Harashima H (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J 11, 13-22 https://doi.org/10.1208/s12248-008-9071-2
  39. Frankel AD, Bredt DS and Pabo CO (1988) Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240, 70-73 https://doi.org/10.1126/science.2832944
  40. Lei XG and Vatamaniuk MZ (2011) Two tales of antioxidant enzymes on cells and diabetes. Antioxid Redox Signal 14, 489-503 https://doi.org/10.1089/ars.2010.3416
  41. Lenzen S, Drinkgern J and Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20, 463-466 https://doi.org/10.1016/0891-5849(96)02051-5
  42. Lundh M, Scully SS, Mandrup-Poulsen T and Wagner BK (2013) Small-molecule inhibition of inflammatory beta cell death. Diabetes Obes Metab 15, 176-184 https://doi.org/10.1111/dom.12158
  43. Rabinovitch A and Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55, 1139-1149 https://doi.org/10.1016/S0006-2952(97)00492-9
  44. Eldor R, Yeffet A, Baum K et al (2006) Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci U S A 103, 5072-5077 https://doi.org/10.1073/pnas.0508166103
  45. Grey ST, Longo C, Shukri T et al (2003) Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J Immunol 170, 6250-6256 https://doi.org/10.4049/jimmunol.170.12.6250
  46. Sakai N, Wada T, Furuichi K et al (2002) p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 17, 998-1004 https://doi.org/10.1093/ndt/17.6.998
  47. Shi Y, Wan X, Shao N, Ye R, Zhang N and Zhang Y (2016) Protective and anti-angiopathy effects of ginsenoside Re against diabetes mellitus via the activation of p38MAPK, ERK1/2 and JNK signaling. Mol Med Rep 14, 4849-4856 https://doi.org/10.3892/mmr.2016.5821
  48. Zhang Y, Mei H, Shan W et al (2016) Lentinan protects pancreatic cells from STZ-induced damage. J Cell Mol Med 20, 1803-1812 https://doi.org/10.1111/jcmm.12865
  49. Riedl SJ and Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5, 897-907 https://doi.org/10.1038/nrm1496
  50. Reed JC (2006) Proapoptotic multidomain Bcl-2/Bax-family protein: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 13, 1378-1386 https://doi.org/10.1038/sj.cdd.4401975
  51. Zhang HJ, Zhang, YN and Teng ZY (2019) Downregulation of miR-16 protects H9c2(2-1) cells against hypoxia/reoxygenation damage by targeting CIAPIN1 and regulation of NF-κB pathway. Mol Med Rep 20, 3113-3122
  52. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 https://doi.org/10.1016/0003-2697(76)90527-3